166 related articles for article (PubMed ID: 16249730)
21. [Bisphosphonates and maxillo-mandibular osteo(chemo)necrosis].
Magremanne M; Vervaet C; Dufrasne L; Declercq I; Legrand W; Daelemans P
Rev Stomatol Chir Maxillofac; 2006 Dec; 107(6):423-8. PubMed ID: 17194993
[TBL] [Abstract][Full Text] [Related]
22. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
[No Abstract] [Full Text] [Related]
23. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
[No Abstract] [Full Text] [Related]
24. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
25. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
26. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Merigo E; Manfredi M; Meleti M; Guidotti R; Ripasarti A; Zanzucchi E; D'Aleo P; Corradi D; Corcione L; Sesenna E; Ferrari S; Poli T; Bonaninil M; Vescovi P
Acta Biomed; 2006 Aug; 77(2):109-17. PubMed ID: 17172192
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
Leite AF; Figueiredo PT; Melo NS; Acevedo AC; Cavalcanti MG; Paula LM; Paula AP; Guerra EN
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):14-21. PubMed ID: 16831667
[TBL] [Abstract][Full Text] [Related]
29. Sore mandible. Bisphosphonate-associated osteonecrosis.
Damm DD; Fantasia JE
Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
[No Abstract] [Full Text] [Related]
30. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
31. Suppurative maxillary sinusitis in patients with bisphosphonate-associated osteonecrosis of the maxilla: report of 2 cases.
Koulocheris P; Weyer N; Liebehenschel N; Otten JE; Gutwald R; Schmelzeisen R
J Oral Maxillofac Surg; 2008 Mar; 66(3):539-42. PubMed ID: 18280390
[No Abstract] [Full Text] [Related]
32. Bisphosphonate-induced osteonecrosis of the maxilla presenting as a cicatricial ectropion.
Malik R; Fernando BS; Laitt RD; Leatherbarrow B
Orbit; 2014 Oct; 33(5):369-71. PubMed ID: 24922331
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case.
Hewson ID
N Z Dent J; 2011 Sep; 107(3):97-100. PubMed ID: 21957837
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
Migliorati CA; Siegel MA; Elting LS
Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
[TBL] [Abstract][Full Text] [Related]
37. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
[No Abstract] [Full Text] [Related]
38. [Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care].
Beke D; Pecherstorfer M
Wien Med Wochenschr; 2008; 158(23-24):702-6. PubMed ID: 19165450
[TBL] [Abstract][Full Text] [Related]
39. [Oral bisphosphonates and CTX. New methods for assessing the degree of risk in maxillo-mandibular osteonecrosis].
Blanc JL; Chossegros C
Rev Stomatol Chir Maxillofac; 2008 Jun; 109(3):205-6. PubMed ID: 18533207
[No Abstract] [Full Text] [Related]
40. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]